UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

The lancet oncology, 2013-02, Vol.14 (2), p.134-140

2013

Volltextzugriff (PDF)

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study

Gynecologic oncology, 2013-04, Vol.129 (1), p.22-27

2013

Volltextzugriff (PDF)

A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial

Mayo Clinic proceedings, 2005-05, Vol.80 (5), p.587-595

2005

Volltextzugriff (PDF)

A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study

Gynecologic oncology, 2014-06, Vol.133 (3), p.537-541

2014

Volltextzugriff (PDF)

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gynecologic oncology, 2012-10, Vol.127 (1), p.70-74

2012

Volltextzugriff (PDF)

A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gynecologic oncology, 2012-06, Vol.125 (3), p.635-639

2012

Volltextzugriff (PDF)

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial

The Lancet (British edition), 2022-02, Vol.399 (10324), p.541-553

2022

Volltextzugriff (PDF)

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients

Current medical research and opinion, 2006-10, Vol.22 (10), p.2041-2053

2006

Volltextzugriff (PDF)

Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)

Gynecologic oncology, 2018-07, Vol.150 (1), p.9-13

2018

Volltextzugriff (PDF)

Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group study

Gynecologic oncology, 2009-09, Vol.114 (3), p.472-479

2009

Volltextzugriff (PDF)

Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative

Cancer, 2016-01, Vol.122 (2), p.230-237

2016

Volltextzugriff (PDF)

Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study

Gynecologic oncology, 2020-09, Vol.158 (3), p.562-569

2020

Volltextzugriff (PDF)

Minority participation in Gynecologic Oncology Group (GOG) Studies

Gynecologic oncology, 2015-08, Vol.138 (2), p.441-444

2015

Volltextzugriff (PDF)

A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial

Gynecologic oncology, 2022-12, Vol.167 (3), p.423-428

2022

Volltextzugriff (PDF)

A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic oncology, 2017-11, Vol.147 (2), p.283-290

2017

Volltextzugriff (PDF)

Impact of Robotics and Laparoscopy on Surgical Skills: A Comparative Study

Journal of the American College of Surgeons, 2007, Vol.204 (1), p.96-101

2007

Volltextzugriff (PDF)

Human serum carotenoid concentrations are related to physiologic and lifestyle factors

The Journal of nutrition, 1996, Vol.126 (1), p.129-137

1996

Volltextzugriff (PDF)

Red blood cell fatty acids and age-related macular degeneration in postmenopausal women

European journal of nutrition, 2022-04, Vol.61 (3), p.1585-1594

2022

Volltextzugriff (PDF)

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

The American journal of cardiology, 2005-02, Vol.95 (4), p.462-468

2005

Volltextzugriff (PDF)

Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness Trial

Mayo Clinic proceedings, 2006-09, Vol.81 (9), p.1177-1185

2006

Volltextzugriff (PDF)

Findings from Optometrists' Practices in Advising about Lifestyle Study

Optometry and vision science, 2020-08, Vol.97 (8), p.598-605

2020

Volltextzugriff (PDF)

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study

Gynecologic oncology, 2011-07, Vol.122 (1), p.111-115

2011

Volltextzugriff (PDF)

Clinical trial methodology in rare gynecologic tumor research: Strategies for success

Gynecologic oncology, 2018-06, Vol.149 (3), p.605-611

2018

Volltextzugriff (PDF)

1 – 25 von 476

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(447)
Mit Volltextzugriff
(403)

Publikationsform

Artikel
(460)
Buchkapitel
(15)
Bücher
(1)

Sprache

Englisch
(476)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study

A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial

A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients

Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)

Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group study

An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor

Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative

Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study

Minority participation in Gynecologic Oncology Group (GOG) Studies

A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience

Impact of Robotics and Laparoscopy on Surgical Skills: A Comparative Study

Human serum carotenoid concentrations are related to physiologic and lifestyle factors

Red blood cell fatty acids and age-related macular degeneration in postmenopausal women

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness Trial

Findings from Optometrists' Practices in Advising about Lifestyle Study

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study

Clinical trial methodology in rare gynecologic tumor research: Strategies for success

Aktive Filter

Suchergebnisse filtern